Navigation Links
Genes May Play Role in Quitting Smoking
Date:6/3/2008

People respond to different treatments based on their genetic make-up, study says

TUESDAY, June 3 (HealthDay News) -- Your ability to kick the smoking habit may have a lot to do with your genetic make-up, a new study finds.

Researchers have found gene patterns that influence a smoker's response to specific smoking-cessation treatments. The researchers identified several genetic variations that appear to indicate the likelihood of success or failure with nicotine replacement therapy and the smoking-cessation drug bupropion (Zyban).

"There is a significant chunk of evidence that the ability to quit smoking has inheritable components," said lead researcher Dr. George R. Uhl, chief of the molecular neurobiology research branch at the U.S. National Institute on Drug Abuse.

"There is no single gene that has variants related to smoking," Uhl said. "There is no gene that even has a large effect. But nevertheless, we have identified a number of different genes that are all contributors to the individual differences in the ability to quit smoking."

The findings were published in the June issue of the Archives of General Psychiatry.

For the study, Uhl's team analyzed the DNA of 550 smokers who were part of smoking-cessation studies. These people had been randomly assigned to receive either nicotine replacement therapy; the antidepressant Zyban, which has been found to help people quit smoking; or a placebo.

The researchers found 41 gene variants linked to smokers who successfully quit using nicotine replacement therapy, and 26 genes that were specific to successful quitting with Zyban.

Uhl said these genetic variants alone aren't enough to predict successful treatment to quit smoking. And, the specific role these genes play still isn't clear, he said.

But, the findings do explain why different people respond to different smoking-cessation treatments, Uhl said.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... (HealthDay News) -- Cocaine users can have abnormal blood ... which can put them at increased risk for heart ... in Chicago compared heart imaging test results from 202 ... illegal drug. Those using cocaine showed subtle abnormalities ... which were considered significant when compared to non-cocaine users ...
(Date:11/18/2014)... November 18, 2014 OpenWorks, one of ... in the 2014 Lincoln Guild Invitational. The John C. ... to support the Phoenix-area Desert Mission community programs. Open ... , The tournament was held at Camelback Golf Club ... support the efforts of Desert Mission — including a ...
(Date:11/18/2014)... 2014 As children head back to ... look at fall as the perfect time to refresh ... , Orange County facial plastic surgeon, has observed a ... At the Gallery of Cosmetic Surgery he has noticed ... non-invasive cosmetic surgery procedures. , “Non-invasive cosmetic treatments ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. ... verge of burning out are more likely to develop heart ... vital exhaustion -- a toxic combination of fatigue, irritability and ... heart disease, researchers report. "In our increasingly busy lives, ... when that stress is left unchecked for a period of ...
(Date:11/17/2014)... CA (PRWEB) November 17, 2014 A ... thousands of patients throughout the country are turning back ... than ever before. This is because the company has ... to their already impressive collection of prescription and non-prescription ... who have incorporated Diet Doc’s best anti-aging ...
Breaking Medicine News(10 mins):Health News:Cocaine Can Cause Heart Problems: Study 2Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3
... trials show some success in helping children , FRIDAY, ... effective in treating juvenile rheumatoid arthritis, according to studies ... (ACR) meeting in Boston. , One study found that ... rheumatoid arthritis, may be a well-tolerated treatment for children ...
... researchers have shown that an immunosuppressive drug used in ... patients with systemic lupus erythematosus (SLE). SLE results in ... joints and kidneys. Its cause is unknown. The findings ... American College of Rheumatology in Boston. , Our findings ...
... Rural/Metro,Corporation (Nasdaq: RURL ) announced it will ... 30, 2007 and fiscal 2007 fourth quarter,and 12 months ... on November,14, 2007. In conjunction, the Company will host ... at 9 a.m. (Pacific)/ 11 a.m.,(Eastern). Also on ...
... Hooper Holmes,Inc. (Amex: HH ), a leading ... the third quarter ended September 30,2007. Third quarter ... the corresponding period of 2006. The Company recorded a ... million, or $(0.16) per share,compared to a net loss ...
... The Signature,Wounds of Operation Iraqi Freedom and ... Veterans for America,s,"Trends in Treatment of ... trends adversely affecting servicemembers and veterans,suffering from ... - traumatic,brain injury (TBI) and psychological traumas., ...
... N.C., EXTON, Pa. and SAN DIEGO, Nov. 9 ... US,provider of oncology equipment sales and service, announced ... with Radiology Oncology Systems, Inc.,(ROS), an oncology and ... Inc., a US provider of oncology equipment service,and ...
Cached Medicine News:Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 3Health News:Hooper Holmes Announces Third Quarter 2007 Results 4Health News:Hooper Holmes Announces Third Quarter 2007 Results 5Health News:Hooper Holmes Announces Third Quarter 2007 Results 6Health News:Hooper Holmes Announces Third Quarter 2007 Results 7Health News:Report Release: Veterans for America Finds Care for PTSD and TBI Inadequate 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3
(Date:11/18/2014)... 2014  AgeneBio, a pharmaceutical company developing innovative ... brain function, today announced that the Company,s founder ... PhD, has received the Society for Neuroscience,s Mika ... years, Dr. Gallagher,s research at Johns Hopkins and ... has led to advancements in the field of ...
(Date:11/17/2014)... Nov. 17, 2014 Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that Jane ... Development, will participate in a live Google Hangout session ... discussing the latest progress in stem cell-based therapies for ... Hangout session is scheduled for Tuesday, November 18, 2014, ...
(Date:11/17/2014)... , November 17, 2014 ... Boston on 20 November   ... discovery and development company, is pleased to announce that ... as one of ten top projects in neuroscience by ... Grau will present an overview of the programme ...
Breaking Medicine Technology:AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Heptares First-in-Class Selective Muscarinic Agonists Chosen as one of top Neuroscience Projects to Watch 2
... AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ("AcelRx"), a ... innovative therapies for the treatment of acute or breakthrough pain, ... ended December 31, 2010. Net loss for the ... common share, compared with a net loss of $3.7 million, ...
... 23, 2011 Actavis Group, an international generic pharmaceuticals ... the US Food & Drug Administration to market Valacyclovir ... 500mg and 1 gram, the generic equivalent of Valtrex® ... for the 12 months ending December 31, 2010, according ...
Cached Medicine Technology:AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 2AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 3AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 4AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 5AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 6Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S. 2
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
The Intradyn Tear-Away Introducer Sheath with Spin-Lock offers a secure dilatorsheath connection, a smooth dilatorsheath transition and a clean, even tear....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Medicine Products: